Compare

Yatsen Holding Ltd vs Zhengye Biotechnology Holding Ltd

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal year	Yatsen Holding Ltd YSG	Zhengye Biotechnology Holding Ltd ZYBT
Year ended	2025-12-31	2025-12-31
Revenue	4.30B CNY	116.36M CNY
Revenue growth (YoY)	+26.7%	-37.6%
Gross margin	78.2%	20.5%
Operating margin	-4.3%	-60.6%
Net margin	-1.9%	-60.0%
Net income	-80.87M CNY	-69.78M CNY
EPS (Diluted)	-0.04 CNY	n/a
Operating cash flow	-94.66M CNY	13.33M CNY
Free cash flow	-136.73M CNY	12.32M CNY
Cash & equivalents	765.38M CNY	n/a
Total assets	3.85B CNY	436.47M CNY
Total liabilities	846.34M CNY	129.76M CNY
Shareholders' equity	3.00B CNY	306.71M CNY
Return on year-end equity	-2.7%	-22.8%
Shares outstanding	n/a	n/a

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal year	Yatsen Holding Ltd	Zhengye Biotechnology Holding Ltd
Latest	4.30B CNY Ended 2025-12-31	116.36M CNY Ended 2025-12-31
1 year earlier	3.39B CNY Ended 2024-12-31	186.36M CNY Ended 2024-12-31
2 years earlier	3.41B CNY Ended 2023-12-31	211.65M CNY Ended 2023-12-31
3 years earlier	3.71B CNY Ended 2022-12-31	260.27M CNY Ended 2022-12-31
4 years earlier	5.84B CNY Ended 2021-12-31	n/a